Abstract P5-08-10: Safety and Tolerability of Paxman Scalp Cooling at Lower Temperatures to Improve Efficacy with Anthracycline Chemotherapy
Type:
PMID:
DOI:
10.1158/1538-7445
Authors:
Goldfarb, S. B., Blinder, V., Gajria, D., Chang, C., Dacunto, A., Park, J., . . . Lacouture, M.
Author Affiliations
Related papers:
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer
ViewScalp Cooling in Preventing Persistent Chemotherapy-Induced Alopecia: A Randomized Controlled Trial
ViewScalp cooling therapy in chemotherapy‑induced alopecia: addressing variability in cooling duration and efficacy
ViewAbstract
Related papers
“Dear hair loss” – illness perceptions of female patients with chemotherapy-induced alopecia
Chemotherapy-induced alopecia (CIA) is one of the most common and distressing side effects of chemotherapy treatment. This study aims to assess the illness perceptions of…
(pre-)Clinical research to understand alopecia and improve cooling results
• Authors: international multi-disciplinary special interest group (SIG) on chemotherapy-induced alopecia (CIA) & scalp cooling • Pathobiology of CIA is still not fully understood1 •…
A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention
Chemotherapy-induced alopecia (CIA) is the most visibly distressing side effect of commonly administered chemotherapeutic agents. Because psychological health has huge relevance to lifestyle, diet, and…
